COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
COVID-19 can have a serious impact effecting the heart during and after infection. The ACC released expert consensus decision pathway for the evaluation and management for the cardiovascular consequences of COVID infection and long-COVID, also known by its official clinical designation as post-acute sequelae of SARS-CoV-2 infection (PASC).

COVID-19 repercussions on cardiac services will be with us for years to come

A new study reveals the damage caused to cardiovascular programs by the COVID-19 pandemic will continue to accrue unless mitigation strategies are implemented quickly. The review found a number of people dying are at home from heart conditions. 

Americans more likely to seek surgical care during COVID if hospital staff are vaccinated.

Americans more likely to seek surgical care during pandemic if hospital staff is vaccinated

A new study found Americans are more likely to have surgery during a pandemic if they are vaccinated, the hospital staff are vaccinated, the surgery is urgent and the surgery is an outpatient procedure.

Edward Fry, MD, is the 2022-23 ACC president.

VIDEO: ACC president shares his key takeaways from ACC 2022

American College of Cardiology (ACC) President Edward T. A. Fry, MD, of the Ascension St. Vincent Hospital in Indianapolis, discusses the first in-person ACC meeting in three years and the impact of COVID-19 on cardiology practice.

Thumbnail

A key update: 1 year later, no signs of long-term heart damage among college athletes who had COVID-19

More than 3,500 college athletes with a confirmed COVID-19 diagnosis were included in the new study. The median follow-up period was more than one full year. 

FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk

The move limits the vaccine to individuals 18 and older for whom other other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as those 18 and older who would otherwise not receive a COVID-19 vaccine.

Thumbnail

How the science behind COVID-19 vaccines could transform care for heart attack patients

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

COVID-19 vaccine associated myocarditis on short-axis 1.5T MRI images of a 19-year-old man who presented with chest pain three days following the second dose of an mRNA COVID-19 vaccine.

New cardiac MRI analysis offers updated insight into long-term impact of vaccine-related myocarditis

Months after their initial myocarditis diagnosis, late gadolinium enhancement (LGE) was observed in 62% of patients on follow-up cardiac MRI.

Thumbnail

Same-day discharge for AFib ablation a success thanks to telehealth

The new analysis, presented during Heart Rhythm 2022, focused on patients treated at a high-volume facility during the COVID-19 pandemic. 

Displaying 57 - 64 of 427

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.